Washington Trust’s Eli Lilly LLY Stock Holding History

Washington Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.1M	Buy	19,653 +359	+2%	+$364K	0.61%	45
2025 Q4	$20.7M	Buy	19,294 +491	+3%	+$469K	0.68%	40
2025 Q3	$14.3M	Buy	18,803 +169	+0.9%	+$126K	0.47%	66
2025 Q2	$14.5M	Buy	18,634 +114	+0.6%	+$88.6K	0.51%	62
2025 Q1	$15.3M	Sell	18,520 -772	-4%	-$642K	0.59%	56
2024 Q4	$14.9M	Sell	19,292 -167	-0.9%	-$138K	0.53%	58
2024 Q3	$17.2M	Buy	19,459 +98	+0.5%	+$88.1K	0.6%	52
2024 Q2	$17.5M	Sell	19,361 -121	-0.6%	-$96.8K	0.64%	48
2024 Q1	$15.2M	Buy	19,482 +590	+3%	+$420K	0.56%	61
2023 Q4	$11M	Buy	18,892 +2,671	+16%	+$1.56M	0.44%	78
2023 Q3	$8.71M	Buy	16,221 +12,922	+392%	+$6.66M	0.38%	82
2023 Q2	$1.55M	Sell	3,299 -65	-2%	-$27.3K	0.07%	121
2023 Q1	$1.16M	Buy	3,364 +38	+1%	+$12.8K	0.05%	134
2022 Q4	$1.22M	Buy	3,326 +250	+8%	+$88.6K	0.06%	127
2022 Q3	$995K	Buy	3,076 +150	+5%	+$47.5K	0.05%	131
2022 Q2	$949K	Sell	2,926 -25	-0.8%	-$7.5K	0.04%	133
2022 Q1	$845K	Hold	2,951	–	–	0.03%	148
2021 Q4	$816K	Sell	2,951 -755	-20%	-$191K	0.03%	152
2021 Q3	$855K	Buy	3,706 +300	+9%	+$74K	0.02%	192
2021 Q2	$782K	Buy	3,406 +100	+3%	+$20.1K	0.02%	193
2021 Q1	$618K	Hold	3,306	–	–	0.02%	195
2020 Q4	$558K	Sell	3,306 -100	-3%	-$14.9K	0.02%	196
2020 Q3	$504K	Buy	3,406 +455	+15%	+$70.4K	0.02%	195
2020 Q2	$480K	Sell	2,951 -309	-9%	-$47.4K	0.02%	185
2020 Q1	$452K	Buy	+3,260	New	+$448K	0.02%	205
2019 Q4	–	Sell	-2,083	Closed	-$237K	–	210
2019 Q3	$237K	Sell	2,083 -1,232	-37%	-$137K	0.01%	206
2019 Q2	$368K	Buy	+3,315	New	+$390K	0.02%	191
2019 Q1	–	Sell	-2,680	Closed	-$310K	–	223
2018 Q4	$310K	Hold	2,680	–	–	0.02%	186
2018 Q3	$288K	Sell	2,680 -947	-26%	-$94.7K	0.02%	197
2018 Q2	$309K	Sell	3,627 -153	-4%	-$12.6K	0.02%	198
2018 Q1	$292K	Hold	3,780	–	–	0.02%	178
2017 Q4	$320K	Sell	3,780 -137	-3%	-$11.7K	0.02%	177
2017 Q3	$335K	Buy	3,917 +143	+4%	+$11.7K	0.02%	166
2017 Q2	$311K	Hold	3,774	–	–	0.02%	168
2017 Q1	$318K	Hold	3,774	–	–	0.02%	167
2016 Q4	$277K	Hold	3,774	–	–	0.02%	179
2016 Q3	$302K	Buy	3,774 +75	+2%	+$6K	0.02%	171
2016 Q2	$292K	Hold	3,699	–	–	0.02%	175
2016 Q1	$266K	Hold	3,699	–	–	0.02%	181
2015 Q4	$312K	Buy	3,699 +175	+5%	+$14.5K	0.02%	171
2015 Q3	$295K	Sell	3,524 -803	-19%	-$67.8K	0.02%	168
2015 Q2	$362K	Buy	4,327 +319	+8%	+$24.3K	0.02%	166
2015 Q1	$291K	Hold	4,008	–	–	0.02%	181
2014 Q4	$277K	Buy	+4,008	New	+$271K	0.02%	180
2014 Q1	–	Sell	-7,133	Closed	-$364K	–	205
2013 Q4	$364K	Buy	7,133 +1,000	+16%	+$50.1K	0.03%	155
2013 Q3	$309K	Sell	6,133 -40	-0.6%	-$2.09K	0.02%	168
2013 Q2	$303K	Buy	+6,173	New	+$336K	0.03%	159

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Washington Trust's LLY Position: Q1 2026 in Review

Washington Trust increased its Eli Lilly (LLY) stake by 1.9% in Q1 2026, buying an estimated $364K and bringing the position to 19,653 shares worth $18.1M. The position accounts for 0.61% of the portfolio, ranked #45.

Washington Trust first reported a position in LLY in Q2 2013 and has held it in 47 quarters since. The position peaked at $20.7M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Washington Trust held 19,653 shares of Eli Lilly worth $18.1M as of Q1 2026.
Washington Trust bought 359 Eli Lilly shares in Q1 2026, an estimated $364K.
Eli Lilly made up 0.61% of Washington Trust's portfolio in Q1 2026, its #45 holding.
Washington Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 47 quarters since.
Washington Trust's Eli Lilly position peaked at $20.7M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.